P/E ratio for Veru (VERU)
P/E ratio as of April 2024 (TTM): -0.9130
According to Veru's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.913043. At the end of 2022 the company had a P/E ratio of -3.69.
P/E ratio history for Veru from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -3.69 | -87.46% |
| 2021 | -29.5 | -106.81% |
| 2020 | 433 | -2682.09% |
| 2019 | -16.8 | 366.61% |
| 2018 | -3.59 | -8.68% |
| 2017 | -3.93 | -65.97% |
| 2016 | -11.6 | -235.43% |
| 2015 | 8.53 | -86.94% |
| 2014 | 65.3 | 238.2% |
| 2013 | 19.3 | 53.36% |
| 2012 | 12.6 | -19% |
| 2011 | 15.6 | -23.47% |
| 2010 | 20.3 | -31.26% |
| 2009 | 29.6 | 66.55% |
| 2008 | 17.8 | -38.79% |
| 2007 | 29.0 | |
| 2005 | -86.0 | 502% |
| 2004 | -14.3 | -32.47% |
| 2003 | -21.2 | 215.13% |
| 2002 | -6.71 | -37.35% |
| 2001 | -10.7 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -4.67 | 411.11% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -0.9953 | 9.01% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.